Rhythm Pharmaceuticals, Inc.
Clinical trials sponsored by Rhythm Pharmaceuticals, Inc., explained in plain language.
-
Daily injection trial aims to curb uncontrollable hunger in rare brain disorder
Disease control Recruiting nowThis study is testing whether a daily injection called setmelanotide can help people aged 4 and older with a rare form of obesity caused by brain injury (hypothalamic obesity). Participants will receive either the real drug or a placebo for 26 weeks to see if it safely reduces bo…
Phase: PHASE3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Weekly shot aims to tame hunger and control weight in rare obesity disorders
Disease control Recruiting nowThis study is testing a new weekly injection called RM-718 to see if it is safe and can help control weight and hunger. It will involve about 150 people, including adults with general obesity and patients with obesity due to specific conditions like Prader-Willi Syndrome or brain…
Phase: PHASE1, PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC